These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
674 related items for PubMed ID: 33837411
1. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway. Liu X, Guo B, Zhang W, Ma B, Li Y. J Biochem; 2021 Oct 12; 170(3):349-362. PubMed ID: 33837411 [Abstract] [Full Text] [Related]
2. Knockdown of long noncoding RNA GAS5 protects human cardiomyocyte-like AC16 cells against high glucose-induced inflammation by inhibiting miR-21-5p-mediated TLR4/NF-κB signaling. Zhao J, Liu B, Li C. Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug 12; 393(8):1541-1547. PubMed ID: 31865425 [Abstract] [Full Text] [Related]
8. An Aza resveratrol-chalcone derivative 6b protects mice against diabetic cardiomyopathy by alleviating inflammation and oxidative stress. You S, Qian J, Sun C, Zhang H, Ye S, Chen T, Xu Z, Wang J, Huang W, Liang G. J Cell Mol Med; 2018 Mar 12; 22(3):1931-1943. PubMed ID: 29327811 [Abstract] [Full Text] [Related]
9. Attenuation of diabetic cardiomyopathy by relying on kirenol to suppress inflammation in a diabetic rat model. Wu B, Huang XY, Li L, Fan XH, Li PC, Huang CQ, Xiao J, Gui R, Wang S. J Cell Mol Med; 2019 Nov 12; 23(11):7651-7663. PubMed ID: 31565849 [Abstract] [Full Text] [Related]
10. MiR-30c/PGC-1β protects against diabetic cardiomyopathy via PPARα. Yin Z, Zhao Y, He M, Li H, Fan J, Nie X, Yan M, Chen C, Wang DW. Cardiovasc Diabetol; 2019 Jan 11; 18(1):7. PubMed ID: 30635067 [Abstract] [Full Text] [Related]
11. Inhibition of microRNA-150-5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose-treated cardiac fibroblasts. Che H, Wang Y, Li Y, Lv J, Li H, Liu Y, Dong R, Sun Y, Xu X, Zhao J, Wang L. J Cell Physiol; 2020 Nov 11; 235(11):7769-7779. PubMed ID: 31710102 [Abstract] [Full Text] [Related]
14. Inhibition of miR-218-5p reduces myocardial ischemia-reperfusion injury in a Sprague-Dawley rat model by reducing oxidative stress and inflammation through MEF2C/NF-κB pathway. Yang Y, Zhao F, Yuan Z, Wang C, Chen K, Xiao W. Int Immunopharmacol; 2021 Dec 11; 101(Pt B):108299. PubMed ID: 34749249 [Abstract] [Full Text] [Related]
18. Growth differentiation factor 11 regulates high glucose-induced cardiomyocyte pyroptosis and diabetic cardiomyopathy by inhibiting inflammasome activation. Zhang J, Wang G, Shi Y, Liu X, Liu S, Chen W, Ning Y, Cao Y, Zhao Y, Li M. Cardiovasc Diabetol; 2024 May 07; 23(1):160. PubMed ID: 38715043 [Abstract] [Full Text] [Related]
19. Inhibiting microRNA-144 abates oxidative stress and reduces apoptosis in hearts of streptozotocin-induced diabetic mice. Yu M, Liu Y, Zhang B, Shi Y, Cui L, Zhao X. Cardiovasc Pathol; 2015 May 07; 24(6):375-81. PubMed ID: 26164195 [Abstract] [Full Text] [Related]
20. Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy. Ni T, Lin N, Lu W, Sun Z, Lin H, Chi J, Guo H. Cardiovasc Drugs Ther; 2020 Jun 07; 34(3):291-301. PubMed ID: 32212062 [Abstract] [Full Text] [Related] Page: [Next] [New Search]